Litcius/Paper detail

miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2

Huiling Wang, Xin Hu, Feng Yang, Hui Xiao

2021Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics34 citationsDOIOpen Access PDF

Abstract

This study was designed to investigate the precise mechanisms of miR-325-3p/S100A2 axis in breast cancer (BC). In this study, we found that the level of miR-325-3p was dramatically increased in BC tissues and cell lines, and the expression of S100A2 was significantly decreased. Also, the high level of miR-325-3p was closely associated with low expression of S100A2 in BC tissues. Moreover, introduction of miR-325-3p significantly promoted proliferation, invasion, and EMT of BC cells. Bioinformatics analysis predicted that the S100A2 was a potential target gene of miR-325-3p. Luciferase reporter assay demonstrated that miR-325-3p could directly target S100A2. In addition, miR-325-3p overexpression had similar effects with knockdown of S100A2 on BC cells. Overexpression of S100A2 in BC cells partially reversed the promoted effects of miR-325-3p mimic. Overexpression of miR-325-3p promoted cell proliferation, invasion, and EMT of BC cells by directly downregulating S100A2 expression.

Topics & Concepts

Gene knockdownCancer researchCell growthReporter geneBreast cancerCell culturemicroRNACellBiologyLuciferaseGene expressionGeneCancerTransfectionGeneticsS100 Proteins and AnnexinsMicroRNA in disease regulationinterferon and immune responses
miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2 | Litcius